133 results on '"Salmi, Andrea"'
Search Results
2. Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
3. Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
4. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
5. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
6. Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
7. Ultrasound-guided insertion of the Elipse® gastric balloon: technical details, learning curve, and perioperative outcome in 36 cases
8. Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose
9. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
10. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
11. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
12. White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths
13. Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.
14. Spatial analysis of the Healthy Built Environment: an application on Cardiovascular Risk Factors in the canton of Geneva
15. The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study
16. Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience
17. Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
18. Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis.
19. ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
20. One-minute liver "digitopsy" for point of care risk stratification of fibrosis in nonalcoholic fatty liver disease
21. Ultrasound and FibroScan®Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis
22. Clinical features of alcohol-related hepatocellular carcinoma (HCC) in Italy: a multicenter prospective survey: 537
23. Tenofovir monotherapy suppressed viral suppression in most field practice, treatment-naïve patients with chronic hepatitis B followed for 3 years in a multicenter European study: 401
24. Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
25. Teaching echoscopy for the early diagnosis of ascites in cirrhosis: assessment of an objective structured clinical examination (OSCE)
26. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study
27. Body Mass Index and Insomnia association with exposure to nighttime noise in the state of Geneva
28. Ultrasound-guided insertion of the Elipse® gastric balloon: technical details, learning curve, and perioperative outcome in 36 cases.
29. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients
30. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study
31. Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in-field multicenter cohort study
32. Psychological distress in duodenal ulcer and acute gastroduodenitis: A controlled study
33. Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience
34. White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths
35. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study
36. Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice
37. Percutaneous Alcohol Injection of Hepatocellular Carcinoma
38. Efficacy of Radiofrequency Ablation of Hepatocellular Carcinoma Associated with Chronic Liver Disease without Cirrhosis
39. Interferon (IFN) vs interferon + amantadine hydrochloride (IFN+A) for treatment of chronic hepatitis C: An ongoing multicentre randomized trial
40. Ultrasound-Guided Fine Needle Biopsy of Pancreatic Masses: Results of a Multicenter Study
41. Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study
42. Natural history of focal nodular hyperplasia of the liver: An ultrasound study
43. HCV-RNA detection in ultrasound-guided fine needle biopsies of liver nodules and surrounding tissue
44. Sonographic study of pneumoperitoneum to avoid intestinal trocar injuries during laparoscopy
45. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications
46. On the rarity of Cruveilhier-Baumgarten's venous hum
47. A randomised, open label, controlled trial on the effect of interferon plus amantadine compared with interferon alone for treatment of chronic hepatitis C
48. Chronic Pelvic Pain and Depression.
49. Is it possible to recognize portal hypertension with continuous-wave Doppler ultrasonography?
50. Sonographic Patent Umbilical Vein: Lack of Specificity for Portal Hypertension.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.